Hematology and Oncology
Home Hematology and Oncology
Inappropriate Use of Fentanyl Preps Seen Despite Awareness
Claims data show many prescribed transmucosal immediate-release fentanyl were opioid-nontolerant
FDA Warns About ‘Miracle’ Young Blood Infusion Treatments
Expensive 'fountain of youth' therapies are unproven, potentially harmful
Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
Incremental cost-effectiveness ratio varies across clinical risk groups, sensitive to patient age
Darolutamide Slows Spread of Castration-Resistant Prostate Cancer
Significant survival benefit seen, adverse events similar between darolutamide and placebo
Risk Factors ID’d for Diffuse Large B-Cell Lymphoma Mortality
In older patients, risk factors include advanced age, DLBCL stage, Charlson Comorbidity Index
Artificial Intelligence Predicts Survival in Epithelial Ovarian Cancer
Radiomic Prognostic Vector IDs patients with median overall survival of less than two years
Hospital Prices Growing Faster Than Physician Prices
Efforts to reduce health care spending should focus on hospital prices
Physical Activity Down Across Chronic Disease Subgroups
Mental health disorders tied to lowest moderate activity; those with CVD have lowest vigorous activity
p, p’-DDT Exposure Linked to Breast Cancer Through Age 54
Risk for breast cancer varies based on timing of first exposure, age at diagnosis
Cancer Death Risk Up for Kidney Transplant, Dialysis Patients
Risk mainly due to preexisting cancers in dialysis patients, de novo cancers in transplant recipients
